Costa C, Delsedime L, Solidoro P, Curtoni A, Bergallo M, Libertucci D, Baldi S, Rinaldi M, Cavallo R
SCDU Virologia, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Molinette, Italy.
Transplant Proc. 2010 May;42(4):1270-4. doi: 10.1016/j.transproceed.2010.03.086.
The monitoring of herpesvirus infection plays a central role in lung transplantation (LT). Herein we evaluated the prevalence of human cytomegalovirus (HCMV), human herpesvirus-6 (HHV-6), human herpesvirus-7 (HHV-7), and Epstein-Barr Virus (EBV) DNA in bronchoalveolar lavage (BAL) and transbronchial biopsy (TBB) specimens from LT patients. We associated the findings with the occurrence of interstitial pneumonia, acute rejection, or organizing pneumonia. Viral DNA was detected using real-time polymerase chain reaction (PCR) on 76 paired samples (BAL and TBB) from 27 patients who were receiving a universal combined prophylaxis (cytomegalovirus [CMV] immunoglobulin [Ig] + gancyclovir or valgancyclovir). Histopathological analysis was performed in accordance with the International Society for Heart and Lung Transplantation (ISHLT) criteria. Overall, HCMV results were positive in 25/76 (32.9%) specimens (BAL and/or TBB); HHV-6 in 16 (21.1%); HHV-7 in 40 (52.6%); and EBV in 13 (17.1%). Interstitial pneumonia was diagnosed in 6/76 (7.9%) cases: 5 (83.3%) were positive to HCMV (combined specimens; P < .0001); 5 (83.3%) to HHV-7; and 2 (33.3%) to EBV. An acute rejection episode was diagnosed in 19/76 (25%) cases: 7 (36.8%) were positive to HCMV; 5 (26.3%) to HHV-6; 10 (52.6%) to HHV-7, and 3 (15.8%) to EBV. No significant association was observed between virus detection or load and acute rejection. Organizing pneumonia was diagnosed in 4/76 (5.3%) cases: 1 (25%) positive to HCMV; 4 (100%) to HHV-6 (P < .05); 2 (50%) to HHV-7; and none to EBV. In conclusion, the prevalence of HCMV tended to be lower than that reported in the literature, confirming the importance of universal combined prophylaxis. HCMV was a relevant agent for interstitial pneumonia; although the small numbers limit the statistical analysis, our data did not support an association between herpesviruses and acute rejection episodes, whereas the role of HHV-6 in the pathogenesis of organizing pneumonia deserves further study. Viral detection on TBB could represent an adjunctive tool to complement that on BAL.
疱疹病毒感染的监测在肺移植(LT)中起着核心作用。在此,我们评估了肺移植患者支气管肺泡灌洗(BAL)和经支气管活检(TBB)标本中人类巨细胞病毒(HCMV)、人类疱疹病毒6型(HHV - 6)、人类疱疹病毒7型(HHV - 7)和爱泼斯坦 - 巴尔病毒(EBV)DNA的流行情况。我们将这些发现与间质性肺炎、急性排斥反应或机化性肺炎的发生情况相关联。使用实时聚合酶链反应(PCR)对来自27例接受通用联合预防(巨细胞病毒[CMV]免疫球蛋白[Ig] + 更昔洛韦或缬更昔洛韦)患者的76对样本(BAL和TBB)进行病毒DNA检测。组织病理学分析按照国际心肺移植学会(ISHLT)标准进行。总体而言,76份标本(BAL和/或TBB)中有25份(32.9%)HCMV结果呈阳性;HHV - 6为16份(21.1%);HHV - 7为40份(52.6%);EBV为13份(17.1%)。76例中有6例(7.9%)诊断为间质性肺炎:5例(83.3%)HCMV呈阳性(联合样本;P <.0001);5例(83.3%)HHV - 7呈阳性;2例(33.3%)EBV呈阳性。76例中有19例(25%)诊断为急性排斥反应:7例(36.8%)HCMV呈阳性;5例(26.3%)HHV - 6呈阳性;10例(52.6%)HHV - 7呈阳性,3例(15.8%)EBV呈阳性。在病毒检测或载量与急性排斥反应之间未观察到显著关联。76例中有4例(5.3%)诊断为机化性肺炎:1例(25%)HCMV呈阳性;4例(100%)HHV - 6呈阳性(P <.05);2例(50%)HHV - 7呈阳性;EBV均为阴性。总之,HCMV的流行率往往低于文献报道,证实了通用联合预防的重要性。HCMV是间质性肺炎的相关病原体;尽管样本量小限制了统计分析,但我们的数据不支持疱疹病毒与急性排斥反应发作之间存在关联,而HHV - 6在机化性肺炎发病机制中的作用值得进一步研究。TBB上的病毒检测可作为补充BAL检测的辅助工具。